Who Supplies Actinomycin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Actinomycin exports, with 184+ registered manufacturers shipping to buyers across 97+ countries — yet a handful of companies dominate the shipments. EUGIA PHARMA SPECIALITIES LIMITED holds the largest share at 61.4% (export value: $1.8M). Close behind, IKRIS PHARMA NETWORK PRIVATE LIMITED (3.4%, $100.6K). VAMA LIFECARE PRIVATE LIMITED (1.5%, $44.1K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Actinomycin? Top Manufacturers & Their Buyers
Flow of Actinomycin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Actinomycin Supplier Network — Key Market Intelligence
The Actinomycin export market from India is led by EUGIA PHARMA SPECIALITIES LIMITED, which alone commands a 61.4% share, shipping $1.8M worth of product across 5 shipments. The second-largest exporter, IKRIS PHARMA NETWORK PRIVATE LIMITED, contributes $100.6K (3.4%) to the overall market. Combined, the top two suppliers alone account for 64.9% of all Actinomycin exports, indicating a relatively concentrated supply base.
Across all 184 tracked manufacturers, the total Actinomycin export value stands at $2.9M from 933 shipments. The market average shipment value is $3.1K. The single largest buyer relationship in terms of trade value is EUGIA US LLC, receiving $1.0M worth of product.
The combined buyer network spans 13 named purchasing companies, including EUGIA US LLC, SANTA CASA DE MISERI, TO THE, EXP CODE, AS PER INVOICE BRAZI and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the first-largest Actinomycin exporter from India, with a market share of 61.4% and a total export value of $1.8M across 5 shipments. Their average shipment value of $360.3K is above the market average of $3.1K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 2 named buyers in our database. EUGIA US LLC is the dominant customer, accounting for 58.1% of this supplier's tracked business. Top customers include:
• EUGIA US LLC — $1.0M across 3 shipments (58.1% of this supplier's total exports)
• EUGIA US LLC — $754.4K across 2 shipments (41.9% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $360.3K is 11362% above the market average of $3.1K, consistent with large-order contracts or value-added formulations.
2IKRIS PHARMA NETWORK PRIVATE LIMITED
IKRIS PHARMA NETWORK PRIVATE LIMITED is the second-largest Actinomycin exporter from India, with a market share of 3.4% and a total export value of $100.6K across 103 shipments. Their average shipment value of $977 is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.
IKRIS PHARMA NETWORK PRIVATE LIMITED serves 5 named buyers in our database. TO THE ORDER OF, is the dominant customer, accounting for 63.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF, — $63.4K across 65 shipments (63.0% of this supplier's total exports)
• TO THE ORDER OF, — $19.2K across 20 shipments (19.1% of this supplier's total exports)
• To The Order — $8.4K across 9 shipments (8.4% of this supplier's total exports)
• SANTA CASA DE MISERI — $6.6K across 7 shipments (6.6% of this supplier's total exports)
• TO THE ORDER OF,ALEX — $3.0K across 3 shipments (3.0% of this supplier's total exports)
Key Insight: IKRIS PHARMA NETWORK PRIVATE LIMITED operates with high shipment frequency (103 shipments) at a per-shipment value of $977, indicating a broad distribution network with many smaller, regular orders.
3VAMA LIFECARE PRIVATE LIMITED
VAMA LIFECARE PRIVATE LIMITED is the third-largest Actinomycin exporter from India, with a market share of 1.5% and a total export value of $44.1K across 59 shipments. Their average shipment value of $747 is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.
VAMA LIFECARE PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE — $18.0K across 24 shipments (40.9% of this supplier's total exports)
• EXP CODE — $10.2K across 14 shipments (23.0% of this supplier's total exports)
• TO THE — $7.9K across 11 shipments (17.9% of this supplier's total exports)
• AS PER INVOICE BRAZI — $7.4K across 10 shipments (16.9% of this supplier's total exports)
• AS PER INVOICE — $588 across 1 shipments (1.3% of this supplier's total exports)
Key Insight: VAMA LIFECARE PRIVATE LIMITED operates with high shipment frequency (59 shipments) at a per-shipment value of $747, indicating a broad distribution network with many smaller, regular orders.
4CELON LABORATORIES PRIVATE LIMITED
CELON LABORATORIES PRIVATE LIMITED is the fourth-largest Actinomycin exporter from India, with a market share of 1.1% and a total export value of $33.0K across 16 shipments. Their average shipment value of $2.1K is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.
CELON LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• SEVEN PHARMA LTDA — $7.8K across 4 shipments (23.7% of this supplier's total exports)
• VERNON TECHNOLOGIES — $7.8K across 4 shipments (23.5% of this supplier's total exports)
• DRAGON PHARMACEUTICA — $6.2K across 3 shipments (18.8% of this supplier's total exports)
• SEVEN PHARMA EL SALV — $5.8K across 3 shipments (17.7% of this supplier's total exports)
• SEVEN PHARMA S.A.C. — $5.4K across 3 shipments (16.3% of this supplier's total exports)
Key Insight: CELON LABORATORIES PRIVATE LIMITED operates with high shipment frequency (16 shipments) at a per-shipment value of $2.1K, indicating a broad distribution network with many smaller, regular orders.
5GNH INDIA PHARMACEUTICALS LIMITED
GNH INDIA PHARMACEUTICALS LIMITED is the fifth-largest Actinomycin exporter from India, with a market share of 0.9% and a total export value of $25.1K across 56 shipments. Their average shipment value of $448 is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.
GNH INDIA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 64.6% of this supplier's tracked business. Top customers include:
• TO THE ORDER — $16.2K across 36 shipments (64.6% of this supplier's total exports)
• TO THE ORDER — $4.8K across 11 shipments (19.2% of this supplier's total exports)
• TO — $2.3K across 5 shipments (9.2% of this supplier's total exports)
• WORLD MEDIC SERVICOS — $1.1K across 3 shipments (4.6% of this supplier's total exports)
• HOSPITAL SAO RAFAEL — $623 across 1 shipments (2.5% of this supplier's total exports)
Key Insight: GNH INDIA PHARMACEUTICALS LIMITED operates with high shipment frequency (56 shipments) at a per-shipment value of $448, indicating a broad distribution network with many smaller, regular orders.
6MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Actinomycin exporter from India, with a market share of 0.0% and a total export value of $0 across 4 shipments. Their average shipment value of $0 is below the market average of $3.1K, reflecting a high-volume, competitive pricing strategy.
Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (4 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Actinomycin Flows
Once Actinomycin leaves the manufacturing plants of companies like EUGIA PHARMA SPECIALITIES LIMITED and IKRIS PHARMA NETWORK PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $2.9M. United States absorbs the largest share at 73.5% ($2.2M), followed by Brazil (8.4%) and Uganda (1.3%).
In United States — the top destination — named importers include EUGIA US LLC, EUGIA US LLC,, AUROLOGISTIC LLC. In Brazil, key buyers are TO THE, EXP CODE, TO THE MANAGER-.
This geographic spread reflects Actinomycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Actinomycin Go? Top Importing Countries & Their Buyers
Trade flow of Actinomycin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Actinomycin imports from India, with a total trade value of $2.2M across 9 shipments — representing a 73.5% share of all Actinomycin exports. The average shipment value of $239.5K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Actinomycin importers in United States: EUGIA US LLC is the largest buyer, accounting for 48.6% ($1.0M) of this market's total imports.
• EUGIA US LLC — $1.0M (48.6% of United States's total)
• EUGIA US LLC, — $754.4K (35.0% of United States's total)
• AUROLOGISTIC LLC — $348.8K (16.2% of United States's total)
Key Insight: United States's per-shipment average of $239.5K (7522% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Actinomycin imports from India.
2Brazil
Brazil ranks as the second-largest destination for Actinomycin imports from India, with a total trade value of $245.8K across 61 shipments — representing a 8.4% share of all Actinomycin exports. The average shipment value of $4.0K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Actinomycin importers in Brazil: TO THE is the largest buyer, accounting for 10.2% ($25.0K) of this market's total imports.
• TO THE — $25.0K (10.2% of Brazil's total)
• EXP CODE — $10.2K (4.1% of Brazil's total)
• TO THE MANAGER- — $8.1K (3.3% of Brazil's total)
Key Insight: Brazil's per-shipment average of $4.0K (28% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Actinomycin imports from India.
3Uganda
Uganda ranks as the third-largest destination for Actinomycin imports from India, with a total trade value of $37.6K across 3 shipments — representing a 1.3% share of all Actinomycin exports. The average shipment value of $12.5K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Actinomycin importers in Uganda: ONCOPHARM SPECIALITY PHARMACY is the largest buyer, accounting for 88.5% ($33.2K) of this market's total imports.
• ONCOPHARM SPECIALITY PHARMACY — $33.2K (88.5% of Uganda's total)
Key Insight: Uganda's per-shipment average of $12.5K (299% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uganda is a key market for Actinomycin imports from India.
4Ethiopia
Ethiopia ranks as the fourth-largest destination for Actinomycin imports from India, with a total trade value of $36.0K across 2 shipments — representing a 1.2% share of all Actinomycin exports. The average shipment value of $18.0K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Actinomycin importers in Ethiopia: ETHIOPIAN PHARMACEUTICALS is the largest buyer, accounting for 70.6% ($25.4K) of this market's total imports.
• ETHIOPIAN PHARMACEUTICALS — $25.4K (70.6% of Ethiopia's total)
Key Insight: Ethiopia's per-shipment average of $18.0K (473% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ethiopia is a key market for Actinomycin imports from India.
5United Arab Emirates
United Arab Emirates ranks as the fifth-largest destination for Actinomycin imports from India, with a total trade value of $31.3K across 0 shipments — representing a 1.1% share of all Actinomycin exports. The average shipment value of $31.3K is above the global average of $3.1K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Arab Emirates's per-shipment average of $31.3K (898% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Actinomycin imports from India.
People Also Ask — Actinomycin Supplier & Trade Network
Who are the top suppliers of Actinomycin from India?+
Which companies buy Actinomycin from Indian manufacturers?+
Where does Actinomycin exported from India go?+
What is the market share of the top Actinomycin supplier from India?+
What is the average shipment value for Actinomycin exports from India?+
Is Actinomycin manufactured in India and exported globally?+
Which country imports the most Actinomycin from India?+
Who are the buyers of Actinomycin in Brazil?+
How concentrated is the Actinomycin supplier market in India?+
How do I find verified buyers for Actinomycin in specific countries?+
Actinomycin Trade Network — Key Takeaways
- 1EUGIA PHARMA SPECIALITIES LIMITED is India's dominant Actinomycin exporter with a 61.4% market share and $1.8M in total exports — making it the single most important sourcing entity in this market.
- 2The top 184 suppliers collectively account for 68.4% of all tracked Actinomycin exports, with a combined trade value of $2.9M.
- 3United States is the largest destination market, absorbing 73.5% of India's Actinomycin exports ($2.2M). Brazil (8.4%) and Uganda (1.3%) follow.
- 4With 933 total shipments averaging $3.1K each, the Actinomycin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include EUGIA US LLC, EUGIA US LLC, SANTA CASA DE MISERI, TO THE — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 2 customers
6 suppliers → 97 countries
Network value: $2.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Actinomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Actinomycin.
- 2.Flow Mapping: 184 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 933 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 97 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
933 Verified Shipments
184 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists